The term for a research design in which neither participants nor experimenters know who receives the treatment is double-blind. This arrangement is intended to reduce the influence of expectations on both sides of a study.
Participants who know they received the treatment may report improvement partly because they expect it to work. Researchers who know each participant's assignment may unintentionally influence instructions, observations, or interpretation. Keeping both groups unaware helps separate the treatment's actual effects from placebo effects and observer bias.
Double-blind does not necessarily mean that everyone involved is unaware. In some studies, data analysts, outcome assessors, or monitoring committees may also be masked; this is sometimes called triple-blind. Modern reporting guidelines prefer naming exactly who was blinded and what information was withheld, because the labels single-blind and double-blind can be used inconsistently.
A double-blind study can still be poorly designed, and blinding may fail if side effects reveal the treatment. It is also difficult or impossible to blind some interventions, such as surgery or physical therapy.